Skip to main content


Fig. 2 | Inflammation and Regeneration

Fig. 2

From: Joint-preserving regenerative therapy for patients with early-stage osteonecrosis of the femoral head

Fig. 2

Regenerative therapy using controlled release of recombinant human fibroblast growth factor. Schematic views and photographs of the surgical procedure using recombinant human fibroblast growth factor (rhFGF)-2-impregnated gelatin hydrogel for patients with precollapse stage of osteonecrosis of the femoral head (ONFH) are shown. a A schema of the surgical procedure administering the rhFGF-2 gelatin hydrogel. The rhFGF-2-impregnated gelatin hydrogel is embedded percutaneously over the lateral aspect of the femur near the level of the lesser trochanter. A small photograph on the left side shows the actual gelatin hydrogel, which is a superior slow-release carrier for growth factors. b A representative intraoperative fluoroscopic image at drilling. c A screenshot of the preoperative planning using navigation software is shown. The yellow area shows the area of ONFH. The surgeon planned the suitable route of drilling (blue screw)

Back to article page